Eris Therapeutics credit rating update affirmed by India Ratings
** Eris Lifesciences [BSE:ERIS] has announced an update regarding the credit rating of its wholly-owned subsidiary, Eris Therapeutics Limited. The update, dated 06 May 2025, informs stakeholders that India Ratings & Research has affirmed the credit rating of Eris Therapeutics Limited. The company conveyed this information in compliance with the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The announcement was made to both the BSE Limited and the National Stock Exchange of India Limited.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
Supplementary Source Documents
News Alerts
Get instant email alerts when Eris Lifesciences publishes news
Free account required • Unsubscribe anytime